Update on Gene Therapy access for UK and Europe
Update on Gene Therapy access for UK and Europe Read More »
NHSBT Removal of maximum age requirements for red cells transfusion to patients including those with Haemoglobinopathies
Joint Statement from NHS Blood & Transplant, National Blood Transfusion Committee, UKTS and Sickle Cell Society Removal of maximum age requirements for red cells transfusion to patients including those with Haemoglobinopathies. NHSBT released a statement in January 2023 requesting Clinical leads responsible for the transfusion of patients with haemoglobinopathies to remove the maximum age requirement
NHS Offers Allo Haematopoietic Stem Cell Transplant for Adults with Transfusion Dependent Thalassaemia
BREAKING NEWS: NHS Offers Allo Haematopoietic Stem Cell Transplant (Allo-HSCT) for Adults with Transfusion Dependent Thalassaemia (TDT)
UKTS launches the 4th Edition (2023) of their Standards
BREAKING NEWS: UKTS launches the 4th Edition (2023) of their “Standards for the Clinical Care of Treatment of Children and Adult’s living with Thalassaemia in the United Kingdom”
UKTS launches the 4th Edition (2023) of their Standards Read More »
UKTS Press Release Exa-Cel for treatment of transfusion – dependent beta thalassaemia
UKTS Press release Outcome of National Institute for Health and Care Excellence (NICE) Technology Appraisal for Exagamglogene autotemcel (Exa-cel) for treating transfusion- dependent beta thalassaemia [ID4015] in individuals 12 years and over.
UKTS Press Release Exa-Cel for treatment of transfusion – dependent beta thalassaemia Read More »
